Viewing Study NCT00566761


Ignite Creation Date: 2025-12-24 @ 12:50 PM
Ignite Modification Date: 2026-01-17 @ 3:52 AM
Study NCT ID: NCT00566761
Status: TERMINATED
Last Update Posted: 2024-05-30
First Post: 2007-11-30
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Treatment of Bevacizumab and Triamcinolone in Treatment or Macular Edema Secondary to CRVO
Sponsor: Asociación para Evitar la Ceguera en México
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module